OBJECTIVE: Mifepristone–misoprostol medical abortion has been approved in the United
States since 2000. US providers have preferred to use vaginal misoprostol because of …

Objective To determine the risks of short term adverse events in adolescent and older
women undergoing medical abortion. Design Population based retrospective cohort study …

Objectives: Describe the history and physical exam findings of abortion complications.
Review the evaluation of patients that have abortion complications. Outline the treatment of …

Medical abortion has been shown to be an effective alternative to surgery for termination of
pregnancy in the late as well as the early first trimester of pregnancy. This review discusses …

Clostridium sordellii is gram positive bacterial pathogen of humans and animals. While the
incidence of human-related C. sordellii infection is low, the mortality rate associated with …

Background: Medical abortion is a safe method of termination of pregnancy when performed
as per guidelines with a success rate of 92-97%. But self-administration of abortion pills is …

Objective: To describe the use of mifepristone in combination with buccal misoprostol in
women undergoing an early medical abortion (EMA) in Australia. Design, setting and …

Objectives To assess the risk of complications in women undergoing termination of
pregnancy (TOP) for fetal defects and to examine the impact of gestational age on the …

Misoprostol–a drug developed and approved originally for the prevention of gastric ulcers–
has shown itself to be safe, effective and acceptable for uterine evacuation in the context of …

To explore the policy implications of increasing access to safe abortion in Nigeria and
Ghana, we developed a computer-based decision analytic model which simulates induced …